Gregory D. Kirk

27.4k total citations · 1 hit paper
271 papers, 10.8k citations indexed

About

Gregory D. Kirk is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Gregory D. Kirk has authored 271 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Epidemiology, 87 papers in Infectious Diseases and 70 papers in Hepatology. Recurrent topics in Gregory D. Kirk's work include HIV, Drug Use, Sexual Risk (72 papers), HIV/AIDS Research and Interventions (67 papers) and Hepatitis B Virus Studies (60 papers). Gregory D. Kirk is often cited by papers focused on HIV, Drug Use, Sexual Risk (72 papers), HIV/AIDS Research and Interventions (67 papers) and Hepatitis B Virus Studies (60 papers). Gregory D. Kirk collaborates with scholars based in United States, France and United Kingdom. Gregory D. Kirk's co-authors include Shruti H. Mehta, David L. Thomas, James J. Goedert, Jacquie Astemborski, David Vlahov, Chloe L. Thio, Sharyne Donfield, Stephen R. Cole, Mary Carrington and Meredith S. Shiels and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

Gregory D. Kirk

258 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

2009 1.6k citations David L. Thomas, Chloe L. Thio et al. profile →

Peers

Countries citing papers authored by Gregory D. Kirk

Since Specialization

Citations

This map shows the geographic impact of Gregory D. Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory D. Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory D. Kirk more than expected).

Fields of papers citing papers by Gregory D. Kirk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory D. Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory D. Kirk. The network helps show where Gregory D. Kirk may publish in the future.

Co-authorship network of co-authors of Gregory D. Kirk

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory D. Kirk. A scholar is included among the top collaborators of Gregory D. Kirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory D. Kirk. Gregory D. Kirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pragmatic Approach to Hepatocellular Carcinoma Diagnosis in High-Incidence, Resource-Limited Settings in Africa 2025 ·JCO Global Oncology ·Gregory D. Kirk, (unknown), Jim Aizire, (unknown), (unknown), Jackson Orem, Tongai Maponga, Moussa Seydi, Gilles Wandeler, Amir M. Mohareb, David L. Thomas, Fred Okuku, Emmanuel Ochola, Ponsiano Ocama	0
2	Dual probe ligation in situ hybridization with rolling-circle amplification for high-plex spatial transcriptomics 2025 ·Biochemistry and Biophysics Reports ·Sarah Maguire, Joel J. Credle, (unknown), (unknown), Boyoung Cha, Dan Xie, Gregory D. Kirk, Debjit Ray, (unknown), (unknown), (unknown), Chiseko Ikenaga, Thomas E. Lloyd, Nicolás J. Llosa, H. Benjamin Larman	0
3	Changes in the Prevalence of Non-AIDS Conditions Among Hospitalized Persons With HIV in the United States and Canada, 2008–2018 2025 ·Clinical Infectious Diseases ·Thibaut Davy-Méndez, Sonia Napravnik, Brenna Hogan, Joseph J. Eron, Kelly A. Gebo, Keri N. Althoff, Richard D. Moore, Michael J. Silverberg, Michael A. Horberg, M. John Gill, Jonathan Colasanti, Ank E. Nijhawan, Maile Karris, Marina B. Klein, Raynell Lang, Catherine R. Lesko, George A. Yendewa, Gregory D. Kirk, Kathleen A. McGinnis, Stephen A. Berry, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
4	Coping strategy as a predictor of illicit drug use among persons who inject drugs. 2025 ·Psychology of Addictive Behaviors ·David W. Sosnowski, Kenneth A. Feder, (unknown), Becky L. Genberg, Sara B. Johnson, Jing Sun, Brion S. Maher, Rashelle J. Musci, Shruti H. Mehta, Gregory D. Kirk	0
5	Hepatitis B Virus DNA and RNA Persist in Liver After Serologic Recovery in Persons With Hepatitis C Virus 2024 ·The Journal of Infectious Diseases ·(unknown), David L. Thomas, Gregory D. Kirk, Shruti H. Mehta, Jacquie Astemborski, Georg M. Lauer, Ashwin Balagopal, Chloe L. Thio	1
6	Characterizing multimorbidity in ALIVE: comparing single and ensemble clustering methods 2024 ·American Journal of Epidemiology ·Jacqueline E. Rudolph, Bryan Lau, Becky L. Genberg, Jing Sun, Gregory D. Kirk, Shruti H. Mehta	0
7	Impact of HLA class I functional divergence on HIV control 2024 ·Science ·Mathias Viard, Colm Ó’hUigín, Yuko Yuki, Arman Bashirova, David R. Collins, Jonathan M. Urbach, Steven M. Wolinsky, Susan Buchbinder, Gregory D. Kirk, James J. Goedert, Nelson L. Michael, David W. Haas, Steven G. Deeks, Bruce D. Walker, Xu G. Yu, Mary Carrington	6
8	Liver Injury Patterns and Hepatic Toxicity among People Living with and without HIV and Attending Care in Urban Uganda 2023 ·International Journal of Hepatology ·(unknown), Rosalind Parkes‐Ratanshi, Gregory D. Kirk, Ponsiano Ocama	0
9	Temporal association of pre-pandemic perceived social support with psychological resilience and mental well-being during the COVID-19 pandemic among people with a history of injection drug use 2023 ·Drug and Alcohol Dependence ·Eshan U. Patel, Jacquie Astemborski, Kenneth A. Feder, Jacqueline E. Rudolph, (unknown), David W. Sosnowski, Gregory D. Kirk, Shruti H. Mehta, Becky L. Genberg	3
10	APOL1 variant alleles associate with reduced risk for opportunistic infections in HIV infection 2021 ·Communications Biology ·Ping An, Efe Sezgın, Gregory D. Kirk, Priya Duggal, (unknown), George W. Nelson, Sophie Limou, Mark L. Van Natta, Douglas A. Jabs, Michelle M. Estrella, Jeffrey B. Kopp, Cheryl A. Winkler	5
11	COVID-19 hospitalization among people with HIV or solid organ transplant in the us 2021 ·Jun‐Ren Sun, Rohit Patel, Vithal Madhira, Amy L. Olex, Evan French, Jasmin Islam, Richard A. Moffitt, Nora Franceschini, Roslyn B. Mannon, Gregory D. Kirk	4
12	Rapid Real-time Tracking of Nonpharmaceutical Interventions and Their Association With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity: The Coronavirus Disease 2019 (COVID-19) Pandemic Pulse Study 2020 ·Clinical Infectious Diseases ·Steven J. Clipman, Amy Wesolowski, Dustin G. Gibson, Smisha Agarwal, Anastasia S. Lambrou, Gregory D. Kirk, Alain Labrique, Shruti H. Mehta, Sunil S. Solomon	21
13	Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019 2020 ·Clinical Infectious Diseases ·(unknown), Jing Sun, Po‐Hung Chen, Peijin Han, (unknown), (unknown), Gregory D. Kirk	14
14	Prevalence and Factors Associated With Liver Fibrosis Among Adult HIV-Infected Patients Attending Urban and Rural Care Clinics in Uganda 2020 ·Open Forum Infectious Diseases ·(unknown), Gregory D. Kirk, Jim Aizire, (unknown), Alex Karabarinde, Rosalind Parkes‐Ratanshi, Ponsiano Ocama	6
15	Hepatitis B virus perceptions and health seeking behaviors among pregnant women in Uganda: implications for prevention and policy 2019 ·BMC Health Services Research ·Joan Nankya-Mutyoba, Jim Aizire, Fredrick Makumbi, Ponsiano Ocama, Gregory D. Kirk	9
16	Building Leadership Capacity for Mission Execution in a Large Academic Department of Medicine 2018 ·The American Journal of Medicine ·Sherita Hill Golden, Eric B Bass, Stephen A. Berry, (unknown), Danelle Cayea, Deidra C. Crews, Sanjay V. Desai, Khalil G. Ghanem, Carrie Herzke, Gregory D. Kirk, Flora Kisuule, Rachel B. Levine, Kieren A. Marr, Brian O’Rourke, Pankaj J. Pasricha, Kimberly S. Peairs, Stuart C. Ray, Samuel C. Durso, David B. Hellmann, Mark E. Anderson	0
17	A Cross Sectional Analysis of the Role of the Antimicrobial Peptide Cathelicidin in Lung Function Impairment within the ALIVE Cohort 2014 ·PLoS ONE ·Allison Lambert, Gregory D. Kirk, Jacquie Astemborski, Enid Neptune, Shruti H. Mehta, Robert A. Wise, Michael Drummond	16
18	Sensitivity Changes over the Course of Infection Increases the Likelihood of Resistance Against Fusion but Not CCR5 Receptor Blockers 2012 ·AIDS Research and Human Retroviruses ·Nikolaos Chatziandreou, Ana Belén Araúz, (unknown), (unknown), (unknown), Shruti H. Mehta, Gregory D. Kirk, Manish Sagar	13
19	Association between obstructive lung disease and markers of HIV infection in a high-risk cohort 2011 ·Thorax ·Michael Drummond, Gregory D. Kirk, Jacquie Astemborski, (unknown), Shruti H. Mehta, John F. McDyer, Robert H. Brown, Robert A. Wise, Christian A. Merlo	74
20	A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals 2009 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Meredith S. Shiels, Stephen R. Cole, Gregory D. Kirk, (unknown)	388

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact